Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
Seenu M Hariprasad1, Levent Akduman2, Joseph A Clever2, Michael Ober3,4, Franco M Recchia5, William F Mieler1,61Department of Ophthalmology and Visual Sciences, Vitreoretinal Service; 6Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, IL, USA; 2Vitreoretinal Service, S...
Guardado en:
Autores principales: | Seenu M Hariprasad, Levent Akduman, Joseph A Clever, Michael Ober, Franco M Recchia, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cfbd84dafaa4a70816a12cff7c70849 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis AK, et al.
Publicado: (2020) -
Cystoid macular edema
por: Tryfon G Rotsos, et al.
Publicado: (2008) -
Topical nepafenac in the treatment of diabetic macular edema
por: David Callanan, et al.
Publicado: (2008) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016) -
Surgical cystotomy for refractory diabetic cystoid macular edema
por: Tripathy K
Publicado: (2018)